Key facts
- This page summarizes Xiaodong Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
Footnote F2
These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
Footnote F3
These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
Footnote F4
These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.